Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 68   

Articles published

PFE 31.94 -0.03 (-0.09%)
price chart
Pfizer: Why Now Is The Best Time To Buy
Pfizer (NYSE:PFE) is in a period of transition right now in an effort to reposition itself as the leader in the pharmaceutical manufacturing industry.
Pfizer Launches Lipitor Mobile App  MediaPost Communications
Pfizer offers Lipitor app as generics hit market  mobihealthnews
Related articles »  
Merck, Pfizer Back Lawmakers Who Oppose Company Products
There was plenty of debate about the new health-care law in the 2010 congressional elections while little, if any, on birth control.
Related articles »  
Goodbye, Lipitor. Pfizer Bids a Farewell
But after spending more than $87 million promoting the medicine, the world's biggest drug company is quietly giving up on its once-great cash cow for good because more generic versions will soon be going on sale.
Related articles »  
Dow Chemical taking Pfizer space
COLLEGEVILLE �Dow Chemical Co. has finalized a long-term lease on 800,000 square feet of space at Pfizer Inc.'s campus here in what is one of the largest lease deals to be struck in the suburban office market.
Fortune 500: Pfizer drops to No. 40 in 2012 rankings
Pfizer sign AP/FILEPfizer came in at No. 40 on the Fortune 500, the only major employer in Southwest Michigan to break the Top 50 of the annual rankings.
Pfizer top pharma firm on Fortune 500  NJBIZ
Related articles »  
Pfizer Names Olivier Brandicourt as President and General Manager, Emerging ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) named Olivier Brandicourt as President and General Manager of the Emerging Markets and Established Products Business Units, effective June 1, 2012.
PPD names new CEO
PPD Names David Simmons Chairman and CEO  WWAY NewsChannel 3
Related articles »  
Pfizer: Alzheimer's Drugs Will Carry Stock To New Highs In 2013
There is a strong market for any drug that can mitigate or even delay the effects of Alzheimer's disease, and if Pfizer became the first company with a drug to market for Alzheimer's disease I think the news could bring Pfizer stock to new highs ...
Pfizer Reports Subpar Lyrica Phase 3 Results  dailyRx
Pfizer Axes Late-Stage Lyrica Study Following Disappointing Results  Fox Business
Related articles »  
Pfizer Lung Drug Stops Deadly Child Cancers in Study
A Pfizer (PFE:US) Inc. drug that has transformed treatment for adult lung cancers caused by a gene defect is now saving children with deadly tumors.
Related articles »  
Merck's Frazier Says He Won't Follow Pfizer in Splitting Company
Merck & Co. (MRK) Chief Executive Officer Ken Frazier said he doesn't plan on breaking up the company by splitting off businesses the way Pfizer Inc. (PFE) and Abbott Laboratories are doing. �My philosophy is fix what is broke, don't do the fad of the ...
Related articles »  
FDA staff question Pfizer arthritis drug benefits
WASHINGTON (Reuters) - U.S. drug reviewers on Monday questioned whether the benefits of Pfizer Inc's experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections.
Pfizer Gets Support For Arthritis Drug Approval  ValueWalk
Pfizer's Arthritis Pill Raises Safety Concerns, FDA Staff Says  Bloomberg
Related articles »